Your session is about to expire
← Back to Search
Surgical Antiseptic Reapplication for Surgical Site Infection
Study Summary
This trial is testing whether re-applying a surgical prep solution to the skin before surgery can help reduce the risk of infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am open to both planned and emergency medical procedures.I am not pregnant.I am scheduled for multiple surgeries on my legs.I am either male or female.I have open wounds or skin abrasions.I am willing and able to follow the study's requirements.I have a skin condition affecting only certain areas.I am 18 years old or older.I have an infection at the site where I will have surgery.I had surgery on my leg below the knee and needed a splint for 2-3 weeks.
- Group 1: reapplication
- Group 2: no reapplication
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the U.S. Food and Drug Administration given its stamp of approval to Chloraprep?
"By our organization's standards, Chloraprep is rated a 3 as it has attained approval after going through its fourth phase of testing."
How many participants does this experiment have capacity for?
"Unfortunately, the recruiting phase for this clinical trial has already concluded. The first post on 2/1/2014 and last update took place on 17th February 2014. Luckily, there are currently 71 trials in need of participants related to surgical antiseptic and 47 trials that use Chloraprep actively enrolling patients."
Are recruitment efforts currently underway for this clinical trial?
"At this time, this trial is not open to participants. The original posting of the research was on February 1st 2014 and it has been last updated on February 17th 2014. Currently, 71 studies are actively seeking candidates for surgical antiseptic trials and 47 trials require patients for Chloraprep therapy."
What other case studies have been conducted with Chloraprep?
"Currently, 47 trials related to Chloraprep are in progress with 18 of them reaching Phase 3. Most experiments using this drug take place in Phillip, Australian Capital Territory; however, 2768 sites across the globe have conducted studies for it."
To what maladies does Chloraprep commonly provide relief?
"Chloraprep is typically used to ward off sepsis, but it also has applications in disinfection, sore throat management and pressure ulcer relief."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger